Cargando…
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease
Acute graft-versus-host disease (GVHD) is the leading cause of non-relapse mortality following allogeneic hematopoietic cell transplantation. The majority of patients non-responsive to front line treatment with steroids have an estimated overall 2-year survival rate of only 10%. Bromodomain and extr...
Autores principales: | Snyder, Katiri J., Choe, Hannah K., Gao, Yandi, Sell, Natalie E., Braunreiter, Kara M., Zitzer, Nina C., Neidemire-Colley, Lotus, Kalyan, Sonu, Dorrance, Adrienne M., Keller, Andrea, Mihaylova, Maria M., Singh, Satishkumar, Sehgal, Lalit, Bollag, Gideon, Ma, Yan, Powell, Ben, Devine, Steven M., Ranganathan, Parvathi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554203/ https://www.ncbi.nlm.nih.gov/pubmed/34722316 http://dx.doi.org/10.3389/fonc.2021.760789 |
Ejemplares similares
-
Role of endothelial cells in graft-versus-host disease
por: Neidemire-Colley, Lotus, et al.
Publicado: (2022) -
Corrigendum: Role of endothelial cells in graft-versus-host disease
por: Neidemire-Colley, Lotus, et al.
Publicado: (2023) -
Selective inhibition of BET bromodomains
por: Filippakopoulos, Panagis, et al.
Publicado: (2010) -
Targeting BET bromodomain proteins in solid tumors
por: Sahai, Vaibhav, et al.
Publicado: (2016) -
BET bromodomain inhibitors synergize with ATR inhibitors in melanoma
por: Veppil Muralidharan, Somsundar, et al.
Publicado: (2017)